AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO…
Clarifai Accelerates Agentic AI Development: MCP Server Hosting and OpenAI Compatibility Enable Smarter Agents, Faster Deployment
WASHINGTON, July 15, 2025 /PRNewswire/ -- Clarifai, a global leader in AI…
GENESIS G90 SELECTED AS OFFICIAL CAR FOR CEREMONIAL AND PROTOCOL USE BY KUWAITS MINISTRY OF INTERIOR
A milestone that underscores Genesis’ growing presence in the region’s official and…
Fellaz Launches Decentralized Entertainment Protocol Stack | Massive Giveaway Live: Win $3,000 Beta Access + Over 2,000 USDT
SINGAPORE, July 4, 2025 /PRNewswire/ -- Web3 entertainment protocol Fellaz has officially…
Velo Protocol: Binance Alpha Listing Accelerates Asia’s Web3 Liquidity Revolution
SINGAPORE, June 18, 2025 /PRNewswire/ -- Velo Protocol (VELO), a pioneer of…
Sarepta Provides Safety Update for ELEVIDYS and Initiates Steps to Strengthen Safety in Non-Ambulatory Individuals with Duchenne
- The Company is developing an enhanced immunosuppressive regimen in consultation with…
XRP News: Vaultro Finance Presale on XRP Ledger Sells Past 48% of Its Native Token Allocation Act Now Before It Sells Out
SINGAPORE, June 14, 2025 (GLOBE NEWSWIRE) -- Vaultro Finance has once again…
Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience
New solution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and…